Company Filing History:
Years Active: 1991-1992
Title: Jozsef Kenderfi: Innovator in Pharmaceutical Compositions
Introduction
Jozsef Kenderfi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid pharmaceutical compositions and aerosol formulations. With a total of 2 patents to his name, Kenderfi's work has the potential to impact the medical industry positively.
Latest Patents
Kenderfi's latest patents include a solid pharmaceutical composition and a process for preparing the same. This invention focuses on a regulated release solid pharmaceutical composition that utilizes nifedipine as the active ingredient. The process involves admixing a solution of nifedipine with hydrophilizing and retarding agents, applying the solution onto an inert carrier, and subsequently compressing the mixture into tablets or filling it into capsules. Another significant patent is an aerosol composition comprising nitroglycerin as the active ingredient, which is free of propellant gas. This innovative formulation aims to enhance the delivery of nitroglycerin in a more efficient manner.
Career Highlights
Kenderfi is associated with Egis Gyogyszergyar, a prominent pharmaceutical company in Hungary. His work at this institution has allowed him to focus on developing innovative solutions that address various medical needs. His contributions have been recognized within the industry, showcasing his expertise in pharmaceutical sciences.
Collaborations
Throughout his career, Kenderfi has collaborated with notable colleagues, including Frigyes Gorgenyi and Margit Csorgo. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of their collective work in the pharmaceutical field.
Conclusion
Jozsef Kenderfi's innovative contributions to pharmaceutical compositions demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of the complexities involved in drug formulation, and his work continues to influence the industry positively.